Contraction induced by hyposmotic swelling was examined in rat tail arteries mounted on a myograph containing a modified Krebs physiological saline solution (PSS) containing 50 mM mannitol (300 mosm/l). Hyposmotic swelling was induced by removing mannitol. In arteries having basal tone or arteries precontracted with K+ or the thromboxane mimetic U-46619, removal of mannitol caused a concentration dependent contraction of rat tail arteries. Concurrent measurement of tension and intracellular calcium [Ca2+]i in arteries loaded with fura-2 showed that both tension and [Ca2+]i increased on exposure to a hyposmotic solution. Removal of endothelium or inhibition of nitric oxide and cyclooxygenase together did not affect contractile responses. Removal of extracellular Ca2+ abolished the contractile response to hyposmotic solution and NiCl2, a nonspecific inhibitor of Ca2+ influx pathways, blocked the rise in [Ca2+]i and tension in response to a hyposmotic solution. Verapamil and nisoldipine, inhibitors of Cav1.2 (L-type) calcium channels significantly reduced the contractile response to a hyposmotic solution. Addition of NiCl2 to nisoldipine caused an additional inhibition of the response to a hyposmotic solution. Inhibition of calcium release from the sarcoplasmic reticulum by ryanodine or cyclopiazonic acid (CPA) did not cause any change in the tension response to a hyposmotic solution. CPA did not significantly inhibit the response to a hyposmotic solution in the presence of NG-methyl-L-arginine, oxyhaemoglobin and indomethacin. We conclude that contraction induced by a hyposmotic solution is largely due to Cav1.2 calcium channels although other Ca2+ influx pathways also contribute.

1.
Davis MJ, Hill MA: Signalling mechanisms underlying the vascular myogenic response. Physiol Rev 1999;79:387–423.
2.
Bevan LJ. Laher I: Pressure and flow-dependent vascular tone. FASEB J 1991;5:2267–2273.
3.
Osol G: Mechanotransduction by vascular smooth muscle. J Vasc Res 1995;32:275–292.
4.
Eskinder H, Harder DR, Lombard JH: Role of the vascular endothelium in regulating the response of small arteries of the dog kidney to transmural pressure elevation and reduced PO2. Circ Res 1990;66:1427–1435.
5.
Dornyei G, Monos E, Kaley G, Koller A: Myogenic responses of isolated rat skeletal muscle venules: Modulation by norepinephrine and endothelium. Am J Physiol 1996;271:H267–H272.
6.
Szekeres M, Nadasy, GL, Kaley G, Koller A: Nitric oxide and prostaglandins modulate pressure-induced myogenic responses of intramural coronary arterioles. J. Cardiovasc Pharmacol 2004;43:242–249.
7.
Hill MA, Zou H, Potocnik SJ, Meninger GA, Davis MJ: Invited review: Arteriolar smooth muscle mechanotransduction: Ca(2+) signaling pathways underlying myogenic reactivity. J Appl Physiol 2001;91:973–983.
8.
Zou H, Ratz PH, Hill MA: Temporal aspects of Ca(2+) and myosin phosphorylation during myogenic and norepinephrine-induced arteriolar constriction. J Vasc Res 2000;37:556–567.
9.
Kirber MT, Ordway RW, Clapp LH, Walsh JV Jr, Singer JJ: Both membrane stretch and fatty acids directly activate large conductance Ca(2+)-activated K+ channels in vascular smooth muscle cells. FEBS Lett 1992;297:24–28.
10.
Wu X, Davis MJ: Characterization of stretch-activated cation current in coronary smooth muscle cells. Am J Physiol Heart Circ Physiol 2001;280:H1751–H1761.
11.
McCarron JG, Crichton CA, Langton PD, MacKenzie A, Smith GL: Myogenic contraction by modulation of voltage-dependent calcium currents in isolated rat cerebral arteries. J Physiol 1997;498:371–379.
12.
Langton PD: Calcium channel currents recorded from isolated myocytes of rat basilar artery are stretch sensitive. J Physiol 1993;471:1–11.
13.
Kimura M, Obara K, Sasase T, Ishikawa T, Tanabe Y, Nakayama K: Specific inhibition of stretch-induced increase in L-type calcium channel currents by herbimycin A in canine basilar arterial myocytes. Br J Pharmacol 2000;130:923–931.
14.
Lyford GL, Strege PR, Shepard A, Ou Y, Ermilov L, Miller SM, Gibbons SJ, Rae JL, Szurszewski JH, Farrugia G: Alpha(1C) (Ca(V)1.2) L-type calcium channel mediates mechanosensitive calcium regulation. Am J Physiol Cell Physiol 2002;283:C1001–C1008.
15.
Narayanan J, Imig M, Roman RJ, Harder DR: Pressurization of isolated renal arteries increases inositol trisphosphate and diacylglycerol. Am J Physiol 1994;266:H1840–H1845.
16.
Tanaka Y, Hata S, Ishiro H, Ishii K, Nakayama K: Stretching releases Ca2+ from intracellular storage sites in canine cerebral arteries. Can J Physiol Pharmacol 1994;72:19–24.
17.
Oike M, Droogmans G, Nilius B: Mechanosensitive Ca2+ transients in endothelial cells from human umbilical vein. Proc Natl Acad Sci USA 1994;91:2940–2944.
18.
Mohanty MJ, Li X: Stretch-induced Ca(2+) release via an IP(3)-insensitive Ca(2+) channel. Am J Physiol 2002;283:C456–C462.
19.
Mulvany MJ, Halpern W: Contractile properties of small arterial resistance vessels in spontaneously hypertensive and normotensive rats. Circ Res 1977;41:19–26.
20.
Jensen PE, Mulvany MJ, Aalkjaer C: Endogenous and exogenous agonist-induced changes in the coupling between [Ca2+]i and force in rat resistance arteries. Pflugers Arch 1992;420:536–543.
21.
Garcha RS, Hughes AD: Inhibition of norepinephrine and caffeine-induced activation by ryanodine and thapsigargin in rat mesenteric arteries. J Cardiovasc Pharmacol 1995;25:840–846.
22.
Piao L, Li Y, Li L, Jin NG, Li ZL, Xu WX: The involvement of calcium mobilization in the calcium-activated potassium currents activated by hyposmotic swelling in gastric antral circular myocytes of the guinea-pig. Jpn J Physiol 2001;51:223–230.
23.
Bibby KJ, McCulloch CA. Regulation of cell volume and [Ca2+]i in attached human fibroblasts responding to anisosmotic buffers. Am J Physiol 1994;266:C1639–C1649.
24.
Lang F, Busch GL, Zempel G, Ditlevsen J, Hoch M, Emerich U, Axel D, Fingerle J, Meierkord S, Apfel H, et al: Ca2+ entry and vasoconstriction during osmotic swelling of vascular smooth muscle cells. Pflugers Arch 1995;431:253–258.
25.
Welsh DG, Nelson MT, Eckman DM, Brayden JE: Swelling-activated cation channels mediate depolarization of rat cerebrovascular smooth muscle by hyposmolarity and intravascular pressure. J Physiol 2000;527:139–148.
26.
Purdy RE, Weber MA: Angiotensin II amplification of alpha-adrenergic vasoconstriction: Role of receptor reserve. Circ Res 1988;63:748–757.
27.
Prins BA, Weber MA, Purdy RE: Norepinephrine amplifies angiotensin II-induced vasoconstriction in rabbit femoral artery. J Pharmacol Exp Ther 1992;262:198–203.
28.
Bhattacharya B, Roberts RE: Enhancement of alpha2-adrenoceptor-mediated vasoconstriction by the thromboxane-mimetic U46619 in the porcine isolated ear artery: Role of the ERK-MAP kinase signal transduction cascade. Br J Pharmacol 2003;139:156–162.
29.
Crane GJ, Garland CJ: Thromboxane receptor stimulation associated with loss of SKCa activity and reduced EDHF responses in the rat isolated mesenteric artery. Br J Pharmacol 2004;142:43–50.
30.
Somlyo AP, Somlyo AV: Ca2+ sensitivity of smooth muscle and nonmuscle myosin II: Modulated by G proteins, kinases, and myosin phosphatase. Physiol Rev 2003;83:1325–1358.
31.
Himpens B, Kitazawa T, Somlyo AP: Agonist-dependent modulation of Ca2+ sensitivity in rabbit pulmonary artery smooth muscle. Pflugers Arch 1990;417:21–28.
32.
Falcone JC, Kuo L, Meininger GA: Endothelial cell calcium increases during flow-induced dilation in isolated arterioles. Am J Physiol 1993;264:H653–H659.
33.
Hecker M, Mulsch A, Bassenge E, Busse R: Vasoconstriction and increased flow: Two principal mechanisms of shear stress-dependent endothelial autacoid release. Am J Physiol 1993;265:H828–H833.
34.
Gschwend S, Henning RH, Pinto YM, de Zeeuw D, van Gilst, WH, Buikema H: Myogenic constriction is increased in mesenteric resistance arteries from rats with chronic heart failure: Instantaneous counteraction by acute AT1 receptor blockade. Br J Pharmacol 2003;7:1317–1325.
35.
Huang A, Koller A: Endothelin and prostaglandin H2 enhance arteriolar myogenic tone in hypertension. Hypertension 1997;30:1210–1215.
36.
Undavia SS, Berger V, Kaley G, Messina EJ: Myogenic responses of isolated adipose tissue arterioles. Microvasc Res 2003;66:140–146.
37.
Wesselman JP, VanBavel E, Pfaffendorf M, Spaan JA: Voltage-operated calcium channels are essential for the myogenic responsiveness of cannulated rat mesenteric small arteries. J Vasc Res 1996;33:32–41.
38.
Kauser K, Clark JE, Masters BS, Ortiz de Montellano PR, Ma YH, Harder DR, Roman RJ: Inhibitors of cytochrome P-450 attenuate the myogenic response of dog renal arcuate arteries. Circ Res 1991;68:1154–1163.
39.
Osol G, Halpern W: Myogenic properties of cerebral blood vessels from normotensive and hypertensive rats. Am J Physiol 1985;249:H914–H921.
40.
Wellman GC, Bonev AD, Nelson MT, Brayden JE: Gender differences in coronary artery diameter involve estrogen, nitric oxide, and Ca(2+)-dependent K+ channels. Circ Res 1996;79:1024–1030.
41.
Hughes AD: Calcium channels in vascular smooth muscle cells. J Vasc Res 1995;32:353–370.
42.
Potocnik SJ, Murphy TV, Kotecha N, Hill MA: Effects of mibefradil and nifedipine on arteriolar myogenic responsiveness and intracellular Ca(2+). Br J Pharmacol 2000;131:1065–1072.
43.
Coats P, Johnston F, MacDonald J, McMurray JJ, Hillier C: Signalling mechanisms underlying the myogenic response in human subcutaneous resistance arteries. Cardiovasc Res 2001;49:828–837.
44.
Moosmang S, Schulla V, Welling A, Feil R, Feil S, Wegener JW, Hofmann F, Klugbauer N: Dominant role of smooth muscle L-type calcium channel Cav1.2 for blood pressure regulation. EMBO J 2003;22:6027–6034.
45.
Anfinogenova YJ, Baskakov MB, Kovalev IV, Kilin AA, Dulin NO, Orlov SN: Cell-volume-dependent vascular smooth muscle contraction: Role of Na(+), K(+), 2Cl(–) cotransport, intracellular Cl(–) and L-type Ca(2+) channels. Pflugers Arch 2004 Aug 4.
46.
Kim CH, Rhee PL, Rhee JC, Kim YI, So I, Kim KW, Park MK, Uhm DY, Kang TM: Hypotonic swelling increases L-type calcium current in smooth muscle cells of the human stomach. Exp Physiol 2000;85:497–504.
47.
VanBavel E, Sorop O, Andreasen D, Pfaffendorf M, Jensen BL: Role of T-type calcium channels in myogenic tone of skeletal muscle resistance arteries. Am J Physiol 2002;283:H2239–H2243.
48.
Ohya Y, Adachi N, Nakamura Y, Setoguchi M, Abe I, Fujishima M: Stretch-activated channels in arterial smooth muscle of genetic hypertensive rats. Hypertension. 1998;31:254–258.
49.
Setoguchi M, Ohya Y, Abe I, Fujishima M: Stretch-activated whole-cell currents in smooth muscle cells from mesenteric resistance artery of guinea-pig. J Physiol 1997;501:343–353.
50.
Welsh DG, Morielli AD, Nelson MT, Brayden JE. Transient receptor potential channels regulate myogenic tone. Circ Res 2002;90:248–250.
51.
Ng LC, Gurney AM: Store-operated channels mediate Ca(2+) influx and contraction in rat pulmonary artery. Circ Res 2001;89:923–929.
52.
Xu H, Zhao H, Tian W, Yoshida K, Roullet JB, Cohen DM: Regulation of a transient receptor potential (TRP) channel by tyrosine phosphorylation. SRC family kinase-dependent tyrosine phosphorylation of TRPV4 on TYR-253 mediates its response to hypotonic stress. J Biol Chem 2003;278:11520–11527.
53.
Muraki K, Iwata Y, Katanosaka Y, Ito T, Ohya S, Shigekawa M, Imaizumi Y: TRPV2 is a component of osmotically sensitive cation channels in murine aortic myocytes. Circ Res 2003;93:829–838.
54.
Wang J, Shimoda LA, Sylvester JT: Capacitative calcium entry and TRPC channel proteins are expressed in rat distal pulmonary arterial smooth muscle. Am J Physiol Lung Cell Mol Physiol 2004;286:L848–L858.
55.
Watanabe J, Karibe A, Horiguchi S, Keitoku M, Satoh S, Takishima T, Shirato K: Modification of myogenic intrinsic tone and [Ca2+]i of rat isolated arterioles by ryanodine and cyclopiazonic acid. Circ Res 1993;73:465–472.
56.
Lang F, Busch GL, Ritter M, Volkl H, Waldegger S, Gulbins E, Haussinger D: Functional significance of cell volume regulatory mechanisms. Physiol Rev 1998;78:247–306.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.